Beam Therapeutics (BEAM) Presents Preclinical Data Highlighting Utility and Durability of BEAM-301 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Beam Therapeutics (NASDAQ:BEAM – Free Report) had its price objective cut by Cantor Fitzgerald from $56.00 to $32.00 in a report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Other equities analysts also recently issued reports about the company. Barclays reduced their price objective on Beam Therapeutics from […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was downgraded by equities research analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Friday, Briefing.com reports. They presently have a $20.00 target price on the stock, down from their previous target price of […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 14,350,000 shares, an increase of 6.2% from the September 15th total of 13,510,000 shares. Based on an average daily trading volume, of 872,300 shares, the short-interest […]
Cantor Fitzgerald Cuts Beam Therapeutics (NASDAQ:BEAM) Price Target to $32 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.